834 related articles for article (PubMed ID: 26498756)
1. Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention.
Tang L; Fang ZF; Zhou SH; Tai S; Ahmed S; Huang F; Shen XQ; Zhao YS; Hu XQ
Heart Vessels; 2016 Sep; 31(9):1456-66. PubMed ID: 26498756
[TBL] [Abstract][Full Text] [Related]
2. Index of microcirculatory resistance predicts long term cardiac systolic function in patients with STEMI undergoing primary PCI.
Qi Y; Gu R; Xu J; Kang L; Liu Y; Wang L; Chen J; Zhang J; Wang K
BMC Cardiovasc Disord; 2021 Feb; 21(1):66. PubMed ID: 33530931
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of M30 and oxidative stress for left ventricular remodeling in patients with anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Türkoğlu C; Gür M; Şeker T; Selek Ş; Koçyiğit A
Coron Artery Dis; 2016 Dec; 27(8):690-695. PubMed ID: 27479531
[TBL] [Abstract][Full Text] [Related]
4. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
[TBL] [Abstract][Full Text] [Related]
5. Platelet counts on admission affect coronary flow, myocardial perfusion and left ventricular systolic function after primary percutaneous coronary intervention.
Sharif D; Abu-Salem M; Sharif-Rasslan A; Rosenschein U
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):632-639. PubMed ID: 27069068
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
Liu ZB; Fu XH; Wei G; Gao JL
Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
[TBL] [Abstract][Full Text] [Related]
7. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
[TBL] [Abstract][Full Text] [Related]
8. Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.
Cheng C; Liu XB; Bi SJ; Lu QH; Zhang J
PLoS One; 2019; 14(8):e0220654. PubMed ID: 31369621
[TBL] [Abstract][Full Text] [Related]
9. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of microvascular resistance index immediately after primary percutaneous coronary intervention on left ventricular remodeling in patients with reperfused anterior acute ST-segment elevation myocardial infarction.
Kitabata H; Kubo T; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kashiwagi M; Ozaki Y; Shiono Y; Shimamura K; Orii M; Hirata K; Tanaka A; Imanishi T; Akasaka T
JACC Cardiovasc Interv; 2013 Oct; 6(10):1046-54. PubMed ID: 24156965
[TBL] [Abstract][Full Text] [Related]
13. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
14. Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention.
Dogdus M; Yenercag M; Ozyasar M; Yilmaz A; Can LH; Kultursay H
Angiology; 2021 Mar; 72(3):221-227. PubMed ID: 32996338
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow.
Gür M; Türkoğlu C; Taşkın A; Uçar H; Börekçi A; Seker T; Gözükara MY; Kaypaklı O; Akyol S; Selek S; Sahin DY; Elbasan Z; Caylı M
Atherosclerosis; 2014 Jun; 234(2):415-20. PubMed ID: 24763406
[TBL] [Abstract][Full Text] [Related]
16. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
[TBL] [Abstract][Full Text] [Related]
17. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
18. Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters.
Durante A; Laricchia A; Benedetti G; Esposito A; Margonato A; Rimoldi O; De Cobelli F; Colombo A; Camici PG
Circ Cardiovasc Imaging; 2017 Jun; 10(6):e005841. PubMed ID: 28592591
[TBL] [Abstract][Full Text] [Related]
19. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction.
Bai S; Fu X; Gu X; Wang Y; Li W; Fan Y; Wei L; Bi X
Coron Artery Dis; 2016 Jun; 27(4):302-10. PubMed ID: 26945186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
